MedTrace Logo

Bashaoor Tarbiyat-e-Aulad Program for Reducing Parenting Stress

NCT07802535 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 127

Last updated 2026-09-03

No results posted yet for this study

Summary

This randomized controlled trial evaluated the effectiveness of the culturally adapted Bashaoor Tarbiyat-e-Aulad (BTA) program, an Urdu adaptation of the Mindful Parenting Program developed by Bögels and Restifo, in reducing parenting stress and improving parent and child outcomes among Pakistani mothers. Mothers of children aged 6-11 years were randomly assigned to either a nine-session BTA intervention or a waitlist control group. Outcomes were assessed at baseline and immediately after the intervention using standardized measures of parenting stress, parenting competence, mindful parenting, parental well-being, and child behavioral and emotional problems. The study aimed to determine whether participation in BTA would reduce parenting stress while enhancing mindful parenting, parental well-being, and children's behavioral and emotional functioning in a non-clinical community sample.

Conditions

  • Parenting Stress
  • Parent Child Relationship
  • Parent Stress

Interventions

BEHAVIORAL

Bashaoor Tarbiyat-e-Aulad

Bashaoor Tarbiyat-e-Aulad (BTA) is a culturally adapted Urdu version of the Mindful Parenting Program. The intervention consisted of nine structured group sessions delivered to mothers of children aged 6-11 years. The program included mindfulness practices, mindful parenting exercises, psychoeducation, emotional awareness and regulation, self-compassion, mindful communication, and home practice activities designed to reduce parenting stress and improve parent-child relationships. Each session was delivered according to a standardized intervention manual.

Sponsors & Collaborators

  • National University of Modern Languages

    lead OTHER

Principal Investigators

  • Uzma Shafiq, PhD Psychology · National University of Modern Languages

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-10
Primary Completion
2022-08-18
Completion
2022-08-20

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07802535 on ClinicalTrials.gov